NMS RESOURCES GLOBAL LTD Q3 RESULTS
Counter-questions for the asking
India's growing population, coupled with higher disposable incomes and consumption, has already begun to devastate our carefully constructed cocoons without our realising it. Competitive manufacturing (leveraging economies of scale, procurement, branding and digitalisation) may be enticing more people to consume more (double effect), accelerating planet-stripping.
IT stocks rally up to 4% as an early indicator of Q1 earnings just gave green signals
Indian IT stocks surged following positive results from Accenture, with Persistent Systems leading the gains. Analysts expect a strong demand environment to drive healthy earnings growth.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
As Modi 3.0 begins, where the economy stands, where it's headed
Narendra Modi is set to begin his third term as PM with a full-strength NDA team, amidst optimism for India's economic future. RBI Governor Shantikanta Das highlighted the country's robust economic growth, strong manufacturing sector, recovering rural demand, and promising investment activity. India's external sector remains resilient, with positive growth prospects ahead.
Apollo Hospitals shares rally 3% after reporting Rs 258 crore profit. Should you buy, sell or hold?
Apollo Hospitals Share Price: Apollo Hospitals shares surged by 3.4% during Friday's early trading session, reaching a peak of Rs 5,955. This uptick followed the company's announcement of a significant 77% year-on-year (YoY) increase in its net profit.
JP Morgan maintains overweight rating on LIC post Q4 results, sees 29% upside
JP Morgan maintains 'Overweight' rating on LIC post Q4 results, setting target price of Rs 1,340. LIC's market share growth and strong earnings drive stock performance.
- Go To Page 1
Divi’s Laboratories shares rally 5% post Q4 results. Should you buy, sell or hold?
Divi’s Laboratories saw a 5% surge in its shares on the BSE during Monday's trading session, reaching a new 52-week high of Rs 4,335. This rise came as brokerages such as Motilal Oswal and InCred expressed bullish sentiment towards the stock, following the company's impressive performance in Q4, where it reported a 68% year-on-year increase in profits, reaching Rs 538 crore.
Senco Gold Q4 Results: PAT rises 24% YoY to Rs 32 crore; revenue jumps 40%
Senco Gold, a listed jewellery company, experienced a significant boost in its net profit during the fourth quarter of FY24, thanks to the surge in gold prices. The net profit increased by 23.6%, reaching Rs 32.17 crore compared to Rs 26.03 crore in the fourth quarter of FY23.
InterGlobe Aviation shares rally 3% after doubling Q4 profit. Brokerages increase target price up to Rs 5,192
InterGlobe Aviation, the parent company of IndiGo Airlines, witnessed a significant uptick in its stock price on Friday, with shares climbing almost 3% on the BSE to reach a new 52-week high of Rs 4,520. This surge followed a more than doubling of the company's Profit After Tax (PAT) to Rs 1,895 crore in the fourth quarter.
ITC Q4 Results: Net profit drops marginally to Rs 5,020 crore
Revenue from operations went up by 1.4% at Rs 17,752.87 crore in the period under review. The company said excluding the agri-business (which was severely impacted due to government restrictions in trade of agri-commodities), the company’s gross revenue during the fourth quarter has gone up by 6% y-o-y.
Paytm shares drop 3% after Q4 results. Should You buy or sell?
Paytm's Q4 results show widened losses and reduced revenue, impacted by disruptions and regulatory actions. Analysts vary: Bernstein sees signs of recovery, Macquarie remains cautious, Motilal Oswal maintains a neutral stance, while JM Financial advises selling.
Grasim Q4 Results: Net profit jumps 39% YoY to Rs 1,908 crore; revenue rises 13%
Grasim Q4 Results: The net profit stood at Rs 1,369 crore in the last year quarter. Revenue from operations increased 13% year-on-year to Rs 37,727 crore in the reporting period, compared with Rs 4,873 crore in the corresponding period of previous year.
Sun Pharma Q4 Results: Profit jumps 34% YoY to Rs 2,654 crore, meets Street estimates
Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed timeline. India formulations sales were Rs 3,707 crore for the fourth quarter, showing growth of 10% over Q4 last year and accounted for 31.4% of total consolidated sales for the quarter.
Zee Entertainment Enterprises shares rise 3% as firm swings back to black in Q4
Zee Entertainment Enterprises experienced a nearly 3% increase in its share price to Rs 144.4 during Tuesday's trading session on the BSE, following the company's announcement of a profit of Rs 13 crore in the March quarter of FY24. This marks a significant turnaround from the loss of Rs 196 crore reported in the same period last year.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Will Nifty hit fresh record high before elections? That depends on these 5 factors
The week may remain lacklustre on the data front as no major economic data releases are scheduled in both the US as well as the Indian market. Indian investors are likely to focus more on the ongoing earnings season as well as stock specific developments. Nifty and Sensex have reached all-time highs driven by US Fed data and expert insights. Key factors that will shape market outlook.
ZEE Entertainment shares rally 5% after Q4 results. Should you buy, sell or hold?
ZEE Share Price: ZEEL swung back to profit in March quarter against loss a year ago. Its total income in the reporting quarter, too, increased 3% YoY to Rs 2,185 core. Goldman Sachs sees partial recovery in revenues as a positive sign.
Medanta Q4 Results: Net profit jumps 26% YoY to Rs 127.3 crore
Global Health (Medanta) reported 26% year-on-year (YoY) jump in net profit to Rs 127.3 crore in Q4FY24 due to increase in revenue growth from matured and new hospitals, along with higher patient volumes.
Vodafone Idea Q4 Results: Net loss widens vs Q3; ARPU rise to Rs 146
Vodafone Idea’s net loss for the fiscal fourth quarter, FY24, widened sequentially to Rs 7,675 crore, dragged by high debt and even as it continued to lose subscribers.
Biocon Q4 Results: Net profit drops 57% to Rs 136 crore
Total revenue grew 1% YoY to Rs 3,966 crore. EBITDA for the quarter declined 16% YoY to Rs 964 crore, representing an EBITDA margin of 24% versus 29% in the same period last year. The gross R&D spends declined 36% YoY to Rs 228 crore in Q4FY24.
GIFT Nifty down 40 points; here's the trading setup for today's session
"We expect this volatility to continue in the near term in the absence of any major positive trigger. Now till Nifty holds below 22000 zones, weakness could be seen towards 21700," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
PNB Q4 results: Net profit surges 160% YoY to Rs 3,010 crore; NII rises 9%
Public sector lender Punjab National Bank (PNB) on Thursday reported a 160% year-on-year (YoY) surge in Q4 net profit at Rs 3,010 crore, while the net interest income (NII) rose to Rs 10,363 crore in the quarter, rising 9% YoY.
India Exim Bank sees 12.3% year-on-year goods exports growth in Q1 FY25
The World Trade Organization (WTO) has predicted global goods trade to slowly recover in 2024 following a contraction last year. The volume of world merchandise trade is projected to increase by 2.6% in 2024 and 3.3% in 2025 after falling 1.2% in 2023, the WTO said last month but cautioned that regional conflicts, geopolitical tensions and economic policy uncertainties pose substantial downside risks to the forecast.
Canara Bank Q4 Results: Profit jumps 18% YoY to Rs 3,757 crore; NII rises 11%
Canara Bank Q4 Results: The company's Board has also recommended a dividend of Rs 16.10 per share, 161% of face value each, for the financial year 2023-24
GIFT Nifty up 5 points; here's the trading setup for today's session
"Although Nifty opens positive, it is witnessing resistance at higher levels, indicating cautiousness among the investors with the progress of both the result season and the Lok Sabha election. We expect this volatile move to continue till the Exit poll. Hence market to remain in a broader range until clarity emerges," said Siddhartha Khemka, Head - Retail Research, Motilal Oswal.
Dr Reddy's Labs Q4 Results: PAT jumps 36% YoY to Rs 1,307 crore; firm declares dividend of Rs 40/share
Dr Reddy's Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.
Godrej Consumer shares surge nearly 8% after Q4 results. Should you buy?
Godrej Consumer Share Price: Shares of Godrej Consumer Products surged 8% to its fresh all-time high of Rs 1,349.65 on BSE in Tuesday's early trade even after reporting a consolidated net loss of Rs 1,893 crore for the quarter ended March 31, 2024.
IDFC First Bank shares fall nearly 6% after Q4 results. Should you invest?
In the January-March quarter, IDFC First Bank disclosed an interest income of Rs 8,219.21 crore, a notable increase from Rs 6,424.35 crore reported in the corresponding period of the previous year. This represents a substantial year-on-year growth of 28%.
HCL Tech shares fall 6% after Q4 results. Should you buy, sell or hold?
HCL Technologies shares dropped 6% after reporting Q4FY24 results. Various brokerages offered different perspectives, with targets ranging from Rs 1,300 to Rs 1,700. The company's performance and guidance for FY25 were key points of analysis.
Load More
